ASCO: Finally, a tool to predict response to chemotherapy before bladder cancer surgery

IMAGE: Thomas Flaig, MD, and colleagues show that COXEN may predict which patients will respond to chemotherapy before bladder cancer surgery view more  Credit: University of Colorado Cancer Center University of Colorado Cancer Center led clinical trial data show that a predictive tool called COXEN may show which bladder cancer patients will respond to pre-surgical chemotherapy,…

Details

Can cannabinoids help treat obsessive-compulsive disorder?

IMAGE: Cannabis and Cannabinoid Research is the premier journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. For more information, visit… view more  Credit: ©2012, Mary Ann Liebert, Inc., publishers New Rochelle, NY, May 30, 2019–The body’s endocannabinoid system, due to the critical role it plays…

Details

Men who choose active surveillance for early prostate cancer often don’t follow monitoring rules

CHICAGO — Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that just 15 percent of a group of men in North Carolina with early-stage prostate cancer who choose active surveillance instead of treatment followed the recommended monitoring guidelines. The findings, presented Sunday, June 2, at the American Society of…

Details